Chemistry
Understand matter: synthesis, molecular recognition, structure and reaction.
CHEMISTRY · BIOENGINEERING · PHARMACEUTICS · COMPUTING · HISTORY
Chemistry gave me a way to ask questions, but those questions did not stay in chemistry. I study how molecules and materials behave in living systems, particularly when tissue is injured and a therapy must reach the right place.
I studied chemistry at Qatar University and later moved into pharmaceutical sciences. My research has taken me through chemical synthesis, biomaterials, pulmonary epithelial injury, developmental imaging, inhaled drug delivery, and biomedical computing. I also write about the history of medicine because I am interested in how explanations become accepted, and in what evidence eventually persuades us to change them.

The beginning of university research and the ACS student chapter.
First-author pulmonary epithelial injury paper.
Biomaterials and tissue-interface engineering to the present day.
Expected MSc completion in pharmaceutical sciences.
Research philosophy / First principles & systems
My research is not organized around a single material or animal model. I begin by understanding the system under study, examining the mechanisms that might explain an observation, and deciding what experiment could overturn my interpretation. The methods change because the problems change.
Understand matter: synthesis, molecular recognition, structure and reaction.
Engineer matter: polymers, plasma activation, surface properties and interfaces.
Interrogate living systems: mechanical forces, imaging, transport and response.
Design interventions: delivery, formulation, exposure and therapeutic consequence.
Examine knowledge: what counted as evidence, how medicines were made and why practices endured.
Evaluate evidence: medical AI, biomedical imaging, Python, model-based pharmaceutics and reproducible research software.
Across these fields runs a second concern: building the laboratories, communities and institutions that allow rigorous science to happen.
Explore the experimental methods and original figures ↗ Quality & process thinking ↗Research practice / Quality & process improvement
I do not see quality management as paperwork added after the science. Whether I am working with a synthesis, an inhaled formulation, a microscopy workflow or an organisational process, I want to know where variation enters, how it is measured and whether the result can be reproduced.
Lean and Six Sigma give that thinking a practical structure. They help separate a recurring process fault from random fluctuation, make a change testable and preserve what was learned. They do not replace chemical or biological mechanism; they help build a more dependable experimental system around it.
Specify a useful endpoint: dose, image quality, assay reliability or cycle time.
Characterise variability, measurement error and process conditions.
Distinguish plausible mechanisms from artefacts and process drift.
Test changes to formulations, protocols or hand-offs using evidence.
Document checks, traceability and limits that keep the method dependable.
Selected professional development / 2021–2025
I have also studied quality management, including SOPs, process mapping, document control, KPIs and audit preparation. My training certificates are listed with their issuing organizations; they are individual qualifications, not institutional accreditations.
Three issuer-specific belt records. Green Belt programme: 17.5 CPD/CEU hours in the supplied credential record.
QMS professional training · 15 hours / three days.
Professional development in testing and calibration laboratory competence.
Training in environmental management systems.
Additional training in food-safety management systems and process assurance.
These are training and issuer-specific credential records, not ASQ Certified Six Sigma Green Belt (CSSGB) status, ISO auditor accreditation or certification of an organisation. The DMAIC illustration is an original typographic graphic, not a certificate scan.
View quality credentials in my academic profile ↗01 / The intellectual journey
In 2011, long before I entered a university laboratory, I was studying anatomy at school. I remember the discipline of looking closely at a biological structure before trying to explain it. Years later, chemistry gave me a more precise language for that same curiosity.
At Qatar University I studied chemistry alongside the history of Arab and Islamic civilization. One field taught me to examine matter experimentally; the other taught me to question how knowledge is recorded, transmitted and sometimes misunderstood. Both demand close reading of evidence.
My research did not advance along a single departmental line. Work on molecular sensing led into living vascular systems and the mechanics of pulmonary injury; materials chemistry led towards pharmaceutical formulations and therapeutic transport. I became interested not only in whether an intervention works, but in why, for whom and under what physical conditions.
Historical research has remained part of that work. The preparation and preservation of a medicine are scientific problems and historical ones. Reading early Arabic medical texts beside modern pharmaceutics has made the distinction between an old question and a new experimental method especially productive for me.
A different kind of experience has also shaped my thinking. A chronic eosinophilic illness affecting my gastrointestinal tract began in 2011, and later helped inspire two published chapters on gastrointestinal immune disease. Read my story and find patient-support organizations ↗
My work moved through chemistry, materials, imaging and pharmaceutics as each set of experiments raised questions that the previous methods could not answer.
JAN 05, 2015 · PERSONAL PHOTO ARCHIVE
OCT 19, 2015 · PERSONAL PHOTO ARCHIVE
MAY 06, 2015 · PERSONAL PHOTO ARCHIVE
Personal experience / Science / Patient support
“No one should have to become a scientist to find reliable answers about their illness.”
Support patients and research ↗I have lived with eosinophilic disease for years, through repeated attacks, treatment and interrupted studies.
I was a teenager when persistent gastrointestinal illness began affecting my life in 2011. Recurrent vomiting and other difficult symptoms were followed by years of medical investigations and treatment. My history has included eosinophilic gastroenteritis and evaluation of a wider hypereosinophilic picture. It took a toll on ordinary routines, and at times on my education, examinations, and research.
I lived with the burdens of prolonged glucocorticoid treatment, and later found greater stability with a six-food elimination diet. I am not presenting my experience as a model for anyone else's treatment, or claiming that the condition has been cured. It has taught me how far the language of a clinical diagnosis can be from the uncertainty a patient lives with.
In 2022, the questions raised by that experience helped inspire two chapters I wrote with colleagues about autoimmune diseases of the gastrointestinal tract. The first covered etiology and pathophysiology; the second examined diagnostics and treatments. These were reviews of the scientific literature, not reports of my own illness. Eosinophilic gastrointestinal disease is not necessarily autoimmune, and I do not equate the two. The chapters are one part of my wider scientific work, but they have particular personal significance.
NOVEMBER 17, 2022 · OPEN ACCESS
First-listed author with collaborators · IntechOpen
Read the published chapter ↗NOVEMBER 29, 2022 · OPEN ACCESS
First-listed author with collaborators · IntechOpen
Read the published chapter ↗Independent charities / Official giving links
Families affected by eosinophilic diseases need reliable information, specialist care and continued research. The four organizations linked below work in this area, and their official pages provide ways to support that work directly.
Campaign Urging Research for Eosinophilic Disease · US 501(c)(3), EIN 20-0351832
Focused on eosinophilic gastrointestinal disease. CURED has funded research, exploratory projects, and trainees, including work connected with CEGIR.
Give directly to CURED How CURED uses donations ↗Verify nonprofit: Charity Navigator ↗American Partnership for Eosinophilic Disorders · US 501(c)(3), EIN 76-0700153
Supports people with eosinophil-associated diseases through education, advocacy, and research. Its official giving page includes one-time gifts and recurring support.
Give directly to APFED Explore patient resources ↗Verify nonprofit: Charity Navigator ↗UK-registered eosinophilic diseases charity · Charity no. 1198883
Provides information and practical support for people and families living with eosinophilic conditions, and connects a wider international community.
Give directly to EOS Network Read about its work ↗Verify UK Charity Commission registration ↗US 501(c)(3) · EIN 45-2406486 · Not rated by Charity Navigator
Started as a Cincinnati family support group in 2008. Today it supports families living with eosinophilic disorders through community connections, education and advocacy.
Give directly to EFC Read its mission ↗ Verify 501(c)(3) listing ↗Independent, verified organizations. APFED and CURED are US 501(c)(3) charities associated with CEGIR patient advocacy; EFC is a separately registered US 501(c)(3) that Charity Navigator lists but does not rate; EOS Network is registered with the UK Charity Commission. All four giving links go directly to the organizations' official websites. I do not collect, receive, or process donations and have no financial relationship with these organizations. Linking them does not imply a formal affiliation or endorsement.
Not in a position to donate? Sharing these official resources, learning about the diseases, or participating in legitimate patient and research communities can also make a difference.
BEYOND THIS PAGE
I am interested in collaborating with researchers and patient organizations on evidence-based writing and research communication about eosinophilic and related inflammatory diseases.
Contact me about patient-focused research communication ↗Research and clinical information
One network following these diseases is the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) ↗, which connects clinical and laboratory research on eosinophilic gastrointestinal diseases.
My account reflects personal experience and is not medical advice. Eosinophilic gastrointestinal diseases are not necessarily autoimmune disorders. None of the organizations listed here sponsors or endorses this personal website.
A selective chronology
Early practical exposure to anatomy begins a lasting interest in living structure and experimental observation.
Undergraduate research begins at Qatar University. I help establish its American Chemical Society student chapter.
Research presentations and chapter representation at the 254th ACS National Meeting, documented in the contemporary press.
Vascular imaging, endothelial cilia, cell-injury mechanics and surface-engineered materials shape my experimental training.
Nanotextile and biomaterials work develop alongside teaching, scientific programming and education ventures.
Inhalable vesicle research, a published oncology patent review and scholarship on historical pharmacy. MSc completion expected in 2027.
From the personal history / 2011–2026
Anatomy lessons in 2011, the creation of QUACS in 2015, international conferences, and laboratory work across the following decade belong to the same story. The visual archive preserves documented moments from that development, with dates retained where they are known.
Explore the dated photo & video archive ↗02 / Selected investigations
The case studies below describe the research question, methods, available evidence and my contribution to each project.
Mechanically induced epithelial injury, pharmacological protection, and the question of what cellular forces do.
Endothelial cilia, embryonic cranial vessels, zebrafish imaging and mechanical stimuli.
Electrospinning, cold plasma, and the relationship between polymer surfaces and function.
Dexamethasone niosomes, proniosomes, formulation and aerosol assessment.
Patent families, mechanism, and translational development of an oncology target.
A peer-reviewed CNN–LSTM and stacking-model pilot study for congenital heart disease detection. My documented work includes ultrasound-data preparation, model evaluation and scientific interpretation.
Python, physicochemical descriptors, material-property databases and reproducible decision-support tools for nanocarrier preformulation, with explicit uncertainty and validation boundaries.
Explore AI & computing portfolio ↗03 / Research methods
An experimental record ranging from chemical synthesis and spectroscopy to plasma engineering, cell culture, cardiovascular models, imaging and quantitative biology. The complete atlas connects each technique with a scientific question and published evidence. Explore the full Techniques Atlas ↗
Methods are classified by hands-on experimental experience, collaborative analysis, current development and formal training. Explore the AI, scientific computing and data-analysis portfolio ↗
Moving evidence / Animal research
Zebrafish heart development and optical observation invite a different kind of biological measurement. The Methods Atlas also preserves a short avian egg-preparation recording from the laboratory archive.
Visual methods index
Published experimental figures from my coauthored research in cell injury, zebrafish imaging, biomaterials and chemical sensing, alongside clearly identified original conceptual illustrations. Each figure links to its paper and attribution.
Bioimaging · QU Biomedical Research Center
At the Biomedical Research Center, I helped develop experimental imaging workflows for work involving zebrafish, pulmonary injury and cardiovascular models. Specimen preparation, image acquisition and analysis all presented different problems. I became especially interested in protocols that another researcher could reproduce, including calibration and the conditions under which images were collected.
Imaging and scientific infrastructure ↗04 / Bibliography
A scholarly bibliography cross-checked against my October 2026 CV, including AI research, pharmaceutical modelling, immunology chapters, materials engineering and historical pharmacy. Published items, accepted manuscripts and chapters with unverified publication details are explicitly distinguished.
05 / History of pharmacy & medicine
I began studying history alongside chemistry because the origin of an idea matters as much to me as the mechanism of a molecule. Historical pharmacy lets me ask what physicians, pharmacists and patients believed a medicine should do, how they made it reproducible, and how material constraints shaped practice.
My historical work begins with what a surviving text actually says and how it was used. In studying medieval pharmacy, I examine instructions for preparation, substitution and storage in their original context, then compare them cautiously with modern pharmaceutical questions.
View historical scholarship ↗Set in Ayyubid–Mamluk Cairo, this study follows Abū al-Munā Dāwūd ibn Abī Naṣr al-Kūhīn al-ʿAṭṭār, a Jewish pharmacist whose Minhāj al-dukkān illuminates the practical decisions behind preparing, substituting and preserving medicines. Formulary texts and surviving prescription evidence reveal how therapeutic reliability was negotiated in practice.
MAHMOUD K. AL-RUWEIDI ET AL. · HISTORY OF PHARMACY AND PHARMACEUTICALS · RESEARCH IN THE HISTORY OF PHARMACYFORTHCOMING · MEDICINES, PHARMACISTS AND THE PRACTICES OF MEDIEVAL CAIRO06 / Essays & public scientific writing
Scientific work also requires public criticism and explanation. These essays examine drug discovery, research institutions, scientific credit, history and the way knowledge enters public life.
07 / In the public record
These reports and interviews were published by universities and other organizations. Their original pages are linked below.
A report naming my participation in the 254th ACS National Meeting and the research presented by our Qatar University delegation.
NOVEMBER 4, 2017 · ORIGINAL REPORT ↗QATAR UNIVERSITY RESEARCH MAGAZINE · ISSUE 11The May 2019 magazine feature names me among the QU undergraduate research team working with collaborators on zebrafish cranial vessels and endothelial cilia.
MAY 2019 · PRINTED PP. 4–5 · READ ORIGINAL PDF ↗08 / Building beyond the laboratory
One lesson from scientific research is that having knowledge and making it accessible are different problems. I have also worked in education, scholarly community-building, and the design of organizations that help people learn and act.
In Majales, Al-Ruweidi is a co-founder and partner working through the venture’s initial founding round. Zawya is part of his wider early-stage education and knowledge-building activities. His contribution lies in concept development, research strategy and programme design.
Discuss collaboration ↗Co-founding and early-stage partnership in knowledge and educational initiatives. Working through the initial founding round, with an emphasis on concept development and research-led community building.
09 / Teaching & scientific community
Building a student scientific chapter taught me something that publications alone could not: access to equipment, experienced researchers and a serious scientific community can change what a student believes is possible. I have remained involved in practical training, research mentoring and scientific events while pursuing research of my own.
My work also includes scientific communication and educational entrepreneurship through Majales and Zawya, writing for DDO, and a continuing independent chemistry circle dating back to 2016. Chem Squad reflects the part of research that begins with friendship, curiosity and weekly discussion. These activities complement the research record; they do not substitute for it.
Served two years as chapter president and subsequently as adviser, developing chemistry outreach, visiting lectures, practical workshops and travel opportunities for students.
Supported delegations and represented student chemistry work at ACS national meetings in Washington, Boston and San Diego.
Organised a biomaterials-focused conference and contributed to scientific presentations, specialist workshops and interdisciplinary dialogue.
Research mentoring, science education and co-founding Arabs in Bio(medical) Engineering, alongside professional and research-methodology workshops.
Judging student research, peer-review activities and writing about research practice and the attribution of scientific contributions.
From the chapter archive / 2015–2019
I helped establish Qatar University's American Chemical Society student chapter in 2015. We organized lectures, laboratory training and public chemistry events, and worked to help students participate in international scientific meetings. The chapter gave us a place to learn from each other and bring other students into chemistry.
The chapter was recognised in December 2015. I served as president for two years, followed by an advisory role during its development.
Coordinated Central Laboratories Unit instrumentation training for 29 students and practical research-methodology sessions.
Chem Talks, public demonstrations, mechanochemistry activities, the Time 0s astrochemistry event and a lecture by historian of chemistry Eric Scerri.
Chapter trips and research presentations associated with ACS meetings in Washington, Boston and San Diego. The 2017 Washington participation is independently documented.
The chapter's Instagram archive preserves contemporary photographs and announcements from these student-led activities. Explore documented science engagement ↗
10 / Academic profile
My central interest is the movement from molecular design to biological function and, eventually, practical therapeutic performance.
My background includes chemistry, pharmaceutical sciences, biomaterials, biological systems, computational approaches and scholarly historical research. The connections between these areas matter more to me than the labels alone.
Read academic CV ↗MSc Pharmaceutical Sciences
Qatar University · Thesis in progress, expected 2027
BSc Chemistry
Qatar University · 2021
Minor: History of Arab and Islamic Civilization
Pulmonary pharmaceutics, therapeutic delivery systems, formulation science and mechanistic drug discovery.
Arabic and Islamic pharmaceutical history, material practices, primary texts and the interpretation of medical knowledge.
Materials chemistry · Molecular sensing · Mechanobiology · Zebrafish biology · Biomedical imaging · Translational research · History of pharmacy.
Qatar · International research and collaboration